Sign up to save your podcasts
Or
Share FDA Approved Therapy for SOD1 Associated ALS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA Approved Therapy for SOD1 Associated ALS
Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Read the related article on the FDA website.
Disclosures can be found at Neurology.org
View all episodes
By American Academy of Neurology
4.7
283283 ratings
Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Read the related article on the FDA website.
Disclosures can be found at Neurology.org
More shows like Neurology® Podcast
View all
NEJM This Week
318 Listeners
JAMA Clinical Reviews
497 Listeners
Practical Neurology Podcast
51 Listeners
Mayo Clinic Talks
290 Listeners
The Curbsiders Internal Medicine Podcast
3,339 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,151 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
195 Listeners
Navigating Neuropsychology
360 Listeners
The Clinical Problem Solvers
512 Listeners
Neurology Minute
132 Listeners
Neurology Exam Prep Podcast
180 Listeners
The Curious Clinicians
369 Listeners
Continuum Audio
79 Listeners